KRW 8040.0
(2.03%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -540.91 KRW | -80.69% |
2022 | -473.98 KRW | 33.41% |
2021 | -711.76 KRW | -300.11% |
2020 | -177.89 KRW | 38.53% |
2019 | -289.38 KRW | -55.21% |
2018 | -186.45 KRW | -106.68% |
2017 | -90.21 KRW | -132.74% |
2016 | -38.76 KRW | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -301.35 KRW | -69.4% |
2024 Q1 | -177.89 KRW | 52.25% |
2023 Q2 | -96.51 KRW | 51.84% |
2023 Q3 | -186.98 KRW | -93.74% |
2023 Q4 | -372.57 KRW | -99.26% |
2023 Q1 | -200.39 KRW | -74.09% |
2023 FY | - KRW | -80.69% |
2022 FY | - KRW | 33.41% |
2022 Q4 | -115.11 KRW | 44.36% |
2022 Q3 | -206.90 KRW | -36.32% |
2022 Q2 | -151.77 KRW | -29.94% |
2022 Q1 | -116.80 KRW | -10.73% |
2021 FY | - KRW | -300.11% |
2021 Q3 | -199.96 KRW | -113.4% |
2021 Q2 | -93.70 KRW | 34.15% |
2021 Q1 | -142.30 KRW | 22.73% |
2021 Q4 | -105.48 KRW | 47.25% |
2020 Q1 | -80.80 KRW | 54.92% |
2020 Q4 | -184.15 KRW | -223.07% |
2020 FY | - KRW | 38.53% |
2020 Q3 | -57.00 KRW | -72.73% |
2020 Q2 | -33.00 KRW | 59.16% |
2019 Q4 | -179.22 KRW | -6.05% |
2019 FY | - KRW | -55.21% |
2019 Q3 | -169.00 KRW | -116.67% |
2019 Q2 | -78.00 KRW | 0.0% |
2018 Q4 | -263.17 KRW | -672.11% |
2018 Q3 | 46.00 KRW | 117.56% |
2018 Q2 | -262.00 KRW | 0.0% |
2018 FY | - KRW | -106.68% |
2017 FY | - KRW | -132.74% |
2016 FY | - KRW | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
HLB Pharmaceutical Co., Ltd | -666.05 KRW | 18.788% |
CMG Pharmaceutical Co., Ltd. | 46.00 KRW | 1275.891% |
Celltrion Pharm, Inc. | 539.00 KRW | 200.354% |
Huons Global Co., Ltd. | 3133.85 KRW | 117.26% |
DongKook Pharmaceutical Co., Ltd. | 1073.13 KRW | 150.405% |
Enzychem Lifesciences Corporation | -109.81 KRW | -392.587% |
Humedix Co., Ltd. | 2512.11 KRW | 121.532% |
Boditech Med Inc. | 1181.00 KRW | 145.801% |
EuBiologics Co., Ltd. | -381.00 KRW | -41.971% |
FutureChem Co.,Ltd | -303.61 KRW | -78.159% |
Huons Co., Ltd. | 4261.00 KRW | 112.694% |
BNC Korea Co., Ltd. | 388.00 KRW | 239.41% |